- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06738888
Renovated Prediction Model for Difficult Transoral and Submental Endoscopic Thyroidectomy
May 2, 2026 updated by: Ling Zhan, Shanghai 6th People's Hospital
Renovated Prediction Model for Difficult. Transoral and Submental Endoscopic Thyroidectomy
The investigators have previously proposed a prediction model for difficult transoral and submental thyroidectomy through a retrospective study.
In order to better promote transoral and submental endoscopic approach for thyroid surgery and to set up an appropriate training course, the investigators aim to renovate and validate the prediction model through a prospective study.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Male sex, age, BMI, neck length and certain thyroid disease such as thyroiditis and hyperthyroidism have been long cited as indicators of a difficult thyroidectomy.
The investiagtors hypothesized that neck extension was critical to the exposure and visualization of the surgical field in the endoscopic thyroidectomy.
Therefore, several measurements were innovatedly integrated into the prediction model, including neck circumference, thyromental distance, sternomental distance, ratio of height-to-thyromental distance, ratio of height-to-sternomental distance.
Study Type
Observational
Enrollment (Estimated)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ling Zhan, Doctor
- Phone Number: 08615821120972
- Email: rebecca0428zhan@163.com
Study Locations
-
-
-
Shanghai, China, 200233
- Recruiting
- Shanghai sixth people's hospital
-
Contact:
- Ling Zhan, Doctor
- Phone Number: 08615821120972
- Email: 15821120972@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients with FNA proven differentiated thyroid cancer, were willing to undergo thyroidectomy and central lymph node dissection via transoral and submental approach.
Patients were well informed about the transoral and submental approach and were aware of the potential benefits and risks.
Patient consented for us to use perioperative data.
Description
Inclusion Criteria:
- Clinical diagnosis of differentiated thyroid cancer with a maximum diameter not exceeding 4 cm
- Clinical diagnosis of benign thyroid nodule with a maximum diameter not exceeding 6 cm
- Absence of suspicious lateral lymph nodes or distant metastases
Exclusion Criteria:
- Participants with fusion or fixation of lymph nodes in the neck
- Participants with history of neck surgery or radiation
- Participants with vocal fold fixation by preoperative fibrolaryngoscope
- Participants with preoperative examination suggestive of extrathyroidal invasion
- Participants with a significantly restricted neck and/or jaw
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Normal transoral and submental thyroidectomy
the remaining of the entire study cases excluding the difficult cases
|
Age, body mass index, gender, thyroid function parameters, lesion size, lesion location, ultrasound data, thyromental distance, neck circumference, sternomental distance, ratio of height-to-thyromental distance, RHTMD, ratio of height-to-sternomental distance, RHSMD
|
|
Difficult transoral and submental thyroidectomy
(1) operative time more than 75% of the overall study cases (2) severe intraoperative injuries :: vascular injury, recurrent laryngeal nerve injury, trachea injury, esophagus injury
|
Age, body mass index, gender, thyroid function parameters, lesion size, lesion location, ultrasound data, thyromental distance, neck circumference, sternomental distance, ratio of height-to-thyromental distance, RHTMD, ratio of height-to-sternomental distance, RHSMD
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with mental nerve injury
Time Frame: through study completion, an average of 1 year
|
a postoperative numbness in the lower lip and submental area
|
through study completion, an average of 1 year
|
|
1.Number of participants with recurrent laryngeal nerve injury 1.Number of participants with recurrent laryngeal nerve injury Number of participants with recurrent laryngeal nerve injury
Time Frame: through study completion, an average of 1 year
|
impaired vocal cord mobility confirmed by postoperative laryngoscopy
|
through study completion, an average of 1 year
|
|
Number of participants with hypoparathyroidism Number of participants with hypoparathyroidism Number of participants with hypoparathyroidism
Time Frame: through study completion, an average of 1 year
|
a postoperative parathyroid hormone level of less than 10 pg/ml a postoperative parathyroid hormone level of less than 10 pg/ml a postoperative parathyroid hormone level of less than 10 pg/ml |
through study completion, an average of 1 year
|
|
operative time
Time Frame: immediately at the end of the surgery
|
operative time was defined as the duration from incision to closure, and was collected from anesthesia record sheet
|
immediately at the end of the surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
degree of pain
Time Frame: approximately 4 hours after surgery and on postoperative day 1
|
pain intensity was assessed using a standard visual analogue score, with a score of 0 to 10 corresponding to no pain to the most severe pain
|
approximately 4 hours after surgery and on postoperative day 1
|
|
hospitalization
Time Frame: Length of stay from hospitalisation to discharge
|
days of hospitalization
|
Length of stay from hospitalisation to discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ling Zhan, Doctor, Shanghai 6th People's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2028
Study Registration Dates
First Submitted
December 11, 2024
First Submitted That Met QC Criteria
December 13, 2024
First Posted (Actual)
December 18, 2024
Study Record Updates
Last Update Posted (Actual)
May 7, 2026
Last Update Submitted That Met QC Criteria
May 2, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025-KY-029(K)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Data are available on request due to privacy or other restrictions.
The data that support the findings of this study are available on request from Ling Zhan.
The data are not publicly available due to them containing information that could compromise research participant privacy.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid Diseases
-
AllerganCompletedHypothyroidism | Thyroid Disease | Euthyroid | Thyroid Gland | Thyroid HormonesUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); University of MichiganCompletedThyroid Cancer | Thyroid Nodule | Benign Thyroid NoduleUnited States
-
Imperial College LondonActive, not recruitingThyroid Cancer | Nodule Solitary ThyroidUnited Kingdom
-
Aarhus University HospitalOdense University Hospital; University of AarhusActive, not recruitingThyroid Cancer | Thyroid Nodule (Diagnosis)Denmark
-
Tseung Kwan O Hospital, Hong KongRecruitingBenign Thyroid Nodule | Suspicious Malignant Thyroid NoduleHong Kong
-
Second Affiliated Hospital of Nanchang UniversitySun Yat-sen University; Beijing Friendship Hospital; Zhejiang University; General... and other collaboratorsActive, not recruitingThyroid | Thyroid Cancer | Thyroid AbnormalitiesChina
-
Sound Blade Medical Inc.Not yet recruitingThyroid Nodules | Thyroid Abnormalities
-
Maria Sklodowska-Curie National Research Institute...CompletedThyroid Cancer | Thyroid Nodule | Thyroid NeoplasmPoland
-
Wuhan UniversityRecruitingThyroid Carcinoma | Thyroid Nodule (Benign) | Ablation; RetinaChina
-
University of CagliariProf. Pietro Giorgio Calò; Dott. Gian Luigi CanuNot yet recruitingThyroid Cancer | Thyroid NoduleItaly
Clinical Trials on Observations on clinicopathological factors influencing the difficulty of surgery
-
Shanghai 6th People's HospitalRecruitingDifferentiated Thyroid CancerChina
-
Shanghai 6th People's HospitalRecruitingThyroid Diseases | Thyroid Cancer, Papillary | Thyroid Cancer, Follicular | Thyroid Cancer | Thyroid NoduleChina
-
Shanghai 6th People's HospitalRecruiting
-
Kirill GromovRigshospitalet, Denmark; Vejle Hospital; Holsterbro Sygehus, DKCompleted
-
Helsinki University Central HospitalTurku University Hospital; Oulu University HospitalCompletedCervical RadiculopathyFinland
-
National Cancer Institute, NaplesRecruiting
-
University of ChesterCompletedMenopause | Metabolic Syndrome, Protection AgainstUnited Kingdom
-
Lei LiUnknownDeep Venous Thrombosis | Gynecologic Neoplasm | Ankle Motion | Abdominal BreathingChina
-
UMC UtrechtRudolf Magnus Institute - University of UtrechtUnknownRefractory Localization-related EpilepsyNetherlands
-
Helsinki University Central HospitalAssistance Publique - Hôpitaux de Paris; Universitaire Ziekenhuizen KU Leuven; Azienda Ospedaliera Universitaria Integrata Verona and other collaboratorsCompletedType A Aortic DissectionSpain, Belgium, Finland, United Kingdom, Germany, Italy, Czechia, France